Further, these BC patients were divided into the following four groups based on the median levels of TC2N and FASN protein: (1) high TC2N expression and high FASN expression, (2) high TC2N expression and low FASN expression, (3) low TC2N expression and high FASN expression, and (4) low TC2N expression and low FASN expression. Here, TC2N is linked to breast cancer.